IMPAX LABORATORIES, INC.

602 W Office Center Dr Ste 200, Fort Washington, Pennsylvania, United States

Also known as:

impax labs

global pharmaceuticals

Clinical Trials

10 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

23.1%

Trial Status Distribution

Active, not recruiting

76.9%

Completed

15.4%

Withdrawn

7.7%

Clinical Trials

Trials sponsored by this organization (13)

Evaluation of the pharmacokinetics and safety of multiple once-daily doses of IPX233 in healthy adult volunteers

Phase 1

Withdrawn

interventional

May 201420 participants

Evaluation of the Pharmacokinetics and Safety of Dihydroergotamine Administered Via Two Intranasal Delivery Devices

Phase 1

Completed

interventional

Mar 201414 participants

Evaluation of the Pharmacokinetics of IPX231 (L0007, C0001) in Healthy Subjects

Completed

interventional

Sep 201320 participants

A Study to Compare IPX066 and Carbidopa / Levodopa / Entacapone (CLE) in Advanced Parkinson’s Disease - ND

Active, not recruiting

Jul 201056 participants

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects with Parkinson’s Disease.

Active, not recruiting

May 2010500 participants

A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson’s Disease - N/A

Active, not recruiting

Jan 2010350 participants

A Study To Evaluate The Safety And Efficacy Of IPX066 in Advanced Parkinsons DiseaseEstudio para evaluar la seguridad y eficacia de IPX066 en la enfermedad de Parkinson avanzada.

Active, not recruiting

Oct 2009350 participants

A Study To Evaluate The Safety And Efficacy Of IPX066In Advanced Parkinson’s Disease

Phase 1

Active, not recruiting

Oct 2009350 participants

Page 1 of 2

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

Approvals

Recent Approvals

Nalbulin

PHILIPPINES

13 April 2022

News

No news articles found

Back to Organizations